Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Infection
100%
Infectious Disease
100%
Susceptibility
35%
Antibiotic Sensitivity
32%
Microorganism
29%
Clinical Microbiology
27%
Enterobacterales
26%
Urinary Tract
23%
Vibrio parahaemolyticus
21%
Staphylococcus Aureus
20%
Gram-Negative Bacteria
20%
Matrix-Assisted Laser Desorption-Ionization
19%
Escherichia coli
19%
Agar
19%
Infectious Agent
18%
Autophagy
16%
Blood Plasma
16%
Haemophilus influenzae
16%
Time-of-Flight Mass Spectrometry
16%
Immunoassay
16%
Cerebrospinal Fluid
12%
Coagulase Negative Staphylococcus
12%
Laboratory Automation
12%
Cohort Effect
12%
Enterobacteriaceae
12%
Encephalitis
12%
Cell Death
11%
Klebsiella pneumoniae
11%
Microflora
11%
Disk Diffusion
11%
Antimicrobial Agent
11%
Pseudomonas aeruginosa
10%
Tryptophan
10%
Colony Forming Unit S
10%
Colony-Forming Unit
10%
Microorganism Detection
9%
Dilution
8%
Actin
8%
Vibrio
8%
Host Cell
8%
Indoleamine 2,3-dioxygenase
8%
DNA Sequence
8%
Kingella kingae
8%
Mueller-Hinton Agar
8%
Mould
8%
Candida Albicans
8%
Proteus mirabilis
8%
Packed Red Blood Cells
8%
Morganella morganii
8%
Anaerobic Organism
8%
Keyphrases
AMPylation
25%
Blood Culture
24%
Susceptibility Testing
20%
Vibrio Parahaemolyticus
19%
Urine Culture
17%
Clinical Laboratory
17%
Blood Culture System
16%
Virtools
16%
Sexually Transmitted Infections
16%
During Pregnancy
16%
Vibrio
16%
Core Fragment
16%
β-core
16%
Bruker Biotyper
16%
HCGβ
16%
Academic Medical Centers
15%
Biotyper
14%
Type III Effector
12%
Urine Specimen
12%
Clinical Microbiology
11%
Post-translational Modification
11%
Threonine
11%
Multiplex
11%
Cell Rounding
11%
Enterobacterales
10%
Clinical Microbiology Laboratory
10%
Disc Diffusion
10%
Hands-on Time
10%
Urinary Tract Infection
9%
Epidemiology
9%
Escherichia Coli
9%
Adenosine 5′-monophosphate
9%
N-methyl-D-aspartate Receptor (NMDAR)
9%
Patient Characteristics
9%
Diagnostic Test
9%
Clinical Characteristics
9%
Healthcare-associated
9%
Health Systems
9%
Respiratory Specimens
9%
95% Confidence Interval
9%
Positive Blood Culture
8%
Carbapenem Resistance
8%
Diagnostic Stewardship
8%
Immunoassay
8%
Mass Spectrometry
8%
BioPlex 2200
8%
Autophagy
8%
Tertiary Care Hospital
8%
Kynurenine
8%
VopS
8%
Medicine and Dentistry
Urine Culture
16%
Diagnostic Testing
15%
Clinician
15%
Diseases
13%
Chorionic Gonadotropin
11%
Sexually Transmitted Disease
11%
Pregnant Woman
11%
Pathogen
11%
Carbapenem
11%
Morbidity
10%
Diagnosis
9%
Antibiotic Resistance
9%
Urinary System
8%
Cerebrospinal Fluid
8%
Cephalosporin Derivative
8%
Immunoassay
8%
Haemophilus influenzae
8%
Carbapenem-Resistant Enterobacteriaceae
8%
Pulmonary Surfactant
8%
Pediatrics
8%
Fetus Lung Maturity
8%
Lung
8%
Encephalitis
8%
Blood Plasma
8%
Urinalysis
8%
Enterobacteriaceae
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Bloodstream Infection
8%
Womens Health
8%
Biological Marker
8%
Carbapenem Derivative
8%
Masking
8%
DNA Sequence
8%
Viral Respiratory Tract Infection
8%
Antimicrobial Stewardship
6%
Laboratory Test
6%
Antiinfective Agent
6%
Synaptosomal Associated Protein 25
5%
Emerging Pathogen
5%
False Negative Result
5%
Public Health
5%
